Jean-Jacques Kiladjian, Professor of Medicine, Head of Clinical Research Department of Inserm (National Institute of Health and Medical Research), shared on LinkedIn:
“I am very pleased that the signing of the framework agreement between Inserm and AP-HP, Assistance Publique – Hôpitaux de Paris was signed today by Didier Samuel and Nicolas Revel at the CIC1427 Clinical Investigation Center in Saint-Louis.
The CICs are the places par excellence where the strengths and skills of the University Hospitals and Inserm converge in the service of clinical research.
I was also very touched by the exchanges that took place during the visit of the CIC between the directors and patients who were able to testify to the importance of these structures in benefiting from therapeutic innovation in diseases that have run out of conventional therapeutic resources.
Congratulations to the teams of Inserm and AP-HP, Assistance Publique – Hôpitaux de Paris who worked for many months to prepare it!”
Other articles featuring Jean-Jacques Kiladjian on OncoDaily.
